Anova vs Ancova [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2013-03-06 16:06 (4853 d 04:40 ago) – Posting: # 10163
Views: 5,299

Hi Pandu & ElMaestro,

:google: ← click here!

❝ Introduction of covariates in statistical models isn't common in bioequivalence.


Yep. Since BE in cross-over studies is based on a within-subject comparison I don’t see a practical advantage. Might be useful to study e.g. a gender-effect for NCEs in NDAs.

❝ Would be funny and challenging, by the way, to simulate 2-stage approaches with covariates :cool:


… especially – if not only – for parallel designs!

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
144 visitors (1 registered, 143 guests [including 14 identified bots]).
Forum time: 21:46 CEST (Europe/Vienna)

Actually, science starts to become interesting
only where it ends.    Justus von Liebig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5